Cipla subsidiary clears USFDA inspection with zero observations

Cipla on Friday said a routine US Food and Drug Administration (USFDA) inspection at its wholly owned subsidiary InvaGen Pharmaceuticals' manufacturing facility in Hauppauge, Long Island, New York.
Read the full report on The Economic Times
Story file
- Section
- Health
- Topics
- Stock market
- First reported by
- The Economic Times
- Reporter
- et online
- Published
- Friday, 23 October 2026, 9:13 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from The Economic Times with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

